Valuation: EBOS Group Limited

Market Cap 3.46B 2.44B 2.18B 2.01B 1.82B 3.41B 231B 24.19B 9.58B 121B 9.15B 8.95B 382B P/E 2027 *
14.8x
P/E 2028 * 12.9x
Enterprise Value 4.48B 3.15B 2.81B 2.6B 2.35B 4.4B 299B 31.26B 12.38B 157B 11.82B 11.57B 494B EV / Sales 2027 *
0.32x
EV / Sales 2028 * 0.3x
Free-Float
90.79%
Yield 2027 *
5.63%
Yield 2028 * 6.2%
1 day+16.99%
1 week+16.99%
Current month-1.29%
1 month-1.29%
3 months-11.54%
6 months-12.94%
Current year-34.34%
1 week 23
Extreme 23
23
1 month 19.66
Extreme 19.66
23
Current year 19.66
Extreme 19.66
46.64
1 year 19.66
Extreme 19.66
46.64
3 years 19.66
Extreme 19.66
47.23
5 years 19.66
Extreme 19.66
47.23
10 years 19.66
Extreme 19.66
47.23
Manager TitleAgeSince
Chief Executive Officer 51 2025-06-30
Director of Finance/CFO - 2024-09-29
Chief Tech/Sci/R&D Officer - 2024-08-04
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 2019-06-30
Director/Board Member 60 2021-06-30
Change 5-day change 1-year change 3-year change Capi.($)
+16.99%+16.99% - - 2.47B
-3.20%+0.44%+53.77%+118.94% 1,165B
-1.63%+2.92%+36.65%+73.73% 645B
+0.23%+0.04%+25.09%+97.28% 504B
-0.31%+3.09%+43.92%+64.55% 380B
-1.70%-0.74%+66.17%+40.17% 363B
-0.68%+2.65%+22.46%+51.48% 297B
-1.20%+3.04%+2.62%+26.97% 269B
-1.40%+1.89%+50.46%+61.38% 237B
-0.30%+0.26%+29.70%+101.90% 195B
Average +0.67%+2.54%+36.76%+70.71% 450.61B
Weighted average by Cap. -1.54%+3.17%+40.63%+81.67%

Financials

2027 *2028 *
Net sales 14.03B 9.86B 8.81B 8.14B 7.37B 13.8B 936B 97.93B 38.77B 491B 37.02B 36.23B 1,547B 14.64B 10.3B 9.19B 8.49B 7.7B 14.4B 977B 102B 40.47B 512B 38.64B 37.82B 1,615B
Net income 228M 160M 143M 132M 120M 224M 15.2B 1.59B 629M 7.96B 601M 588M 25.1B 263M 185M 165M 153M 138M 259M 17.58B 1.84B 728M 9.21B 695M 680M 29.04B
Net Debt 1.01B 712M 636M 588M 533M 996M 67.63B 7.07B 2.8B 35.43B 2.67B 2.62B 112B 974M 685M 612M 565M 512M 959M 65.06B 6.8B 2.69B 34.08B 2.57B 2.52B 107B
Projected Income Statement - Annual - EBOS Group Limited
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - EBOS Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
16.74AUD
Average target price
23.25AUD
Spread / Average Target
+38.87%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - EBOS Group Limited